{
 "awd_id": "1015677",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Fellowship Award",
 "awd_titl_txt": "EAPSI:  ETS Factor Redundancy in Embryonic Blood and Endothelial Cell Specification",
 "cfda_num": "47.079",
 "org_code": "01090000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Anne Emig",
 "awd_eff_date": "2010-06-01",
 "awd_exp_date": "2011-05-31",
 "tot_intn_awd_amt": 5617.0,
 "awd_amount": 5617.0,
 "awd_min_amd_letter_date": "2010-06-03",
 "awd_max_amd_letter_date": "2010-06-03",
 "awd_abstract_narration": null,
 "awd_arra_amount": 0.0,
 "dir_abbr": "O/D",
 "org_dir_long_name": "Office Of The Director",
 "div_abbr": "OISE",
 "org_div_long_name": "Office of International Science and Engineering",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Matthew",
   "pi_last_name": "Salanga",
   "pi_mid_init": "C",
   "pi_sufx_name": "",
   "pi_full_name": "Matthew C Salanga",
   "pi_email_addr": "",
   "nsf_id": "000549121",
   "pi_start_date": "2010-06-03",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "Salanga                 Matthew        C",
  "inst_street_address": "",
  "inst_street_address_2": "",
  "inst_city_name": "Tucson",
  "inst_state_code": "AZ",
  "inst_state_name": "Arizona",
  "inst_phone_num": "",
  "inst_zip_code": "857240001",
  "inst_country_name": "United States",
  "cong_dist_code": "07",
  "st_cong_dist_code": "AZ07",
  "org_lgl_bus_name": "",
  "org_prnt_uei_num": "",
  "org_uei_num": ""
 },
 "perf_inst": {
  "perf_inst_name": "Salanga                 Matthew        C",
  "perf_str_addr": "",
  "perf_city_name": "Tucson",
  "perf_st_code": "AZ",
  "perf_st_name": "Arizona",
  "perf_zip_code": "857240001",
  "perf_ctry_code": "US",
  "perf_cong_dist": "07",
  "perf_st_cong_dist": "AZ07",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "731600",
   "pgm_ele_name": "EAPSI"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "5941",
   "pgm_ref_txt": "NEW ZEALAND"
  },
  {
   "pgm_ref_code": "5978",
   "pgm_ref_txt": "EAST ASIA AND PACIFIC PROGRAM"
  },
  {
   "pgm_ref_code": "7316",
   "pgm_ref_txt": "EAPSI"
  }
 ],
 "app_fund": [
  {
   "app_code": "0110",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "040100",
   "fund_code": "01001011DB",
   "fund_name": "NSF RESEARCH & RELATED ACTIVIT",
   "fund_symb_id": "040100"
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2010,
   "fund_oblg_amt": 5617.0
  }
 ],
 "por": {
  "por_cntn": "<div class=\"porColContainerWBG\">\n<div class=\"porContentCol\"><p>This research was focused on understanding the role of neutrophil shed membrane-bound microparticles in modulating the innate immune response. Neutrophils are one of several cell types that comprise the white blood cell compartment of whole blood. Neutrophils are migratory and rush to sights of infection, inflammation and injury, where they can engulf foreign bodies such as bacteria, effectively clearing the region of invaders. In addition to clearing of foreign bodies from a site of injury or infection, neutrophils are known to secrete factors that signal to the immune system facilitating immune responses like inflammation. However, dysregulation of this process may contribute to excessive tissue damage from uncontrolled inflammation. A better understanding of exactly how neutrophils communicate with the immune system is essential for the development of novel drugs and therapies aimed and manipulating the immune response and mitigating tissue damage resulting from immune dysregulation.</p>\n<p>&nbsp;</p>\n<p>The zebrafish embryo is an excellent model for these studies because they contain blood cells with near identical functions to humans, such that our results easily translate to human biology. Additionally transgenic lines and their innate optical transparency allow for real-time in vivo imaging of neutrophil activity, which is a feature quite unique to zebrafish. The laboratory of Drs. Phil and Kathryn Crosier at the University of Auckland&rsquo;s College of Medicine are experts in the immune system and use the zebrafish as a model system in understanding the intersection of the immune system and blood development. Among the transgenic zebrafish lines in the Crosier lab, is a line which neutrophils fluoresce green via expression of a membrane linked green fluorescent protein, allowing direct observation of neutrophils in vivo. High-resolution analysis of these fluorescent cells lead to the observation that membrane-bound microparticles were shed by neutrophils near the site of a bacterial infection in the embryo. Though membrane-bound microparticles have been studied in other organisms and cell types very little is known about neutrophil derived microparticles, and direct observation of the shedding has not been reported. This research has been able to show that neutrophil derived microparticles are enriched at the site of bacterial infection, and seem to come from extensions called filopodia, which &ldquo;break&rdquo; away from the cell body. The next step in this research is to isolate these particles and examine their contents with the hypothesis that they will contain components involved in immune signalling cascades. It is in identifying and characterizing these components, which holds tremendous potential in therapeutic development.</p>\n<p>&nbsp;</p><br>\n<p>\n\t\t\t\t      \tLast Modified: 06/30/2011<br>\n\t\t\t\t\tModified by: Matthew&nbsp;C&nbsp;Salanga</p>\n</div>\n<div class=\"porSideCol\"></div>\n</div>",
  "por_txt_cntn": "\nThis research was focused on understanding the role of neutrophil shed membrane-bound microparticles in modulating the innate immune response. Neutrophils are one of several cell types that comprise the white blood cell compartment of whole blood. Neutrophils are migratory and rush to sights of infection, inflammation and injury, where they can engulf foreign bodies such as bacteria, effectively clearing the region of invaders. In addition to clearing of foreign bodies from a site of injury or infection, neutrophils are known to secrete factors that signal to the immune system facilitating immune responses like inflammation. However, dysregulation of this process may contribute to excessive tissue damage from uncontrolled inflammation. A better understanding of exactly how neutrophils communicate with the immune system is essential for the development of novel drugs and therapies aimed and manipulating the immune response and mitigating tissue damage resulting from immune dysregulation.\n\n \n\nThe zebrafish embryo is an excellent model for these studies because they contain blood cells with near identical functions to humans, such that our results easily translate to human biology. Additionally transgenic lines and their innate optical transparency allow for real-time in vivo imaging of neutrophil activity, which is a feature quite unique to zebrafish. The laboratory of Drs. Phil and Kathryn Crosier at the University of Auckland\u00c6s College of Medicine are experts in the immune system and use the zebrafish as a model system in understanding the intersection of the immune system and blood development. Among the transgenic zebrafish lines in the Crosier lab, is a line which neutrophils fluoresce green via expression of a membrane linked green fluorescent protein, allowing direct observation of neutrophils in vivo. High-resolution analysis of these fluorescent cells lead to the observation that membrane-bound microparticles were shed by neutrophils near the site of a bacterial infection in the embryo. Though membrane-bound microparticles have been studied in other organisms and cell types very little is known about neutrophil derived microparticles, and direct observation of the shedding has not been reported. This research has been able to show that neutrophil derived microparticles are enriched at the site of bacterial infection, and seem to come from extensions called filopodia, which \"break\" away from the cell body. The next step in this research is to isolate these particles and examine their contents with the hypothesis that they will contain components involved in immune signalling cascades. It is in identifying and characterizing these components, which holds tremendous potential in therapeutic development.\n\n \n\n\t\t\t\t\tLast Modified: 06/30/2011\n\n\t\t\t\t\tSubmitted by: Matthew C Salanga"
 }
}